Aurinia Pharmaceuticals I...

NASDAQ: AUPH · Real-Time Price · USD
12.27
0.18 (1.49%)
At close: Aug 15, 2025, 3:59 PM
12.44
1.43%
After-hours: Aug 15, 2025, 06:40 PM EDT

Aurinia Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
83.43M 48.88M 94.17M 231.9M
Short-Term Investments
275.04M 301.61M 295.22M 234.18M
Long-Term Investments
n/a 201K n/a n/a
Other Long-Term Assets
823K 1.52M 13.34M 11.84M
Receivables
36.54M 24.09M 13.48M 15.41M
Inventory
39.23M 39.7M 24.75M 19.33M
Other Current Assets
1.13M 1.03M 1.33M 796K
Total Current Assets
446.6M 424.8M 442.54M 513.32M
Property-Plant & Equipment
98.87M 116.57M 8.56M 9.8M
Goodwill & Intangibles
4.36M 4.98M 6.42M 8.4M
Total Long-Term Assets
104.05M 123.26M 28.32M 30.04M
Total Assets
550.64M 548.06M 470.86M 543.37M
Account Payables
5.19M 4.33M 3.09M 3.88M
Deferred Revenue
11M 4.81M 3.15M 31.07M
Short-Term Debt
15.07M 26.91M 936K 1.06M
Other Current Liabilities
66.5M 29.3M 17.22M 16.41M
Total Current Liabilities
97.76M 77.19M 46.11M 40.65M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
11.11M 10.91M 12.17M 15.95M
Total Long-Term Liabilities
75.4M 92.92M 19.32M 23.63M
Total Liabilities
173.17M 170.11M 65.42M 64.28M
Total Debt
79.37M 97.61M 8.09M 8.74M
Common Stock
1.19B 1.2B 1.19B 1.18B
Retained Earnings
-936.57M -942.32M -864.3M -756.12M
Comprehensive Income
-647K -730K -1.06M -852K
Shareholders Equity
377.48M 377.95M 405.44M 479.09M
Total Investments
275.04M 301.81M 295.22M 234.18M